<DOC>
	<DOCNO>NCT00672490</DOCNO>
	<brief_summary>To compare efficacy safety quetiapine fumarate give mono-therapy adjunct therapy lithium treatment patient acute mania bipolar disorder . Patients document clinical diagnosis bipolar mania accord DSM-IV criterion ( 296.4X Bipolar I Disorder , Most Recent Episode Manic ; 296.0X Bipolar I Disorder , Single Manic Episode ) require YMRS total score â‰¥20 enrolment randomisation</brief_summary>
	<brief_title>Quetiapine Fumarate ( Seroquel ) Mono-Therapy Adjunct Lithium Treatment Patients With Acute Mania Bipolar Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<criteria>Provision write informed consent initiation study related procedure . Patients deem incapable providing informed consent maybe enrol write informed consent obtain patient 's Legally Authorized Representative . Documented clinical diagnosis meeting DSMIV criterion follow : 296.4X Bipolar I Disorder , Most Recent Episode Manic 296.0X Bipolar I Disorder , Single Manic Episode Have YMRS score least 20 score least 4 2 follow 4 YMRS item enrolment randomisation : Irritability , Speech , Content , Disruptive/Aggressive Behaviour . Female patient childbearing potential must negative urine pregnancy test enrolment willing use reliable method birth control , i.e. , barrier method , oral contraceptive , implant , dermal contraception , longterm injectable contraceptive , intrauterine device , tubal ligation , study . Be able understand comply requirement study , judge investigator . Manic episode judge either : direct physiological consequence treatment medical condition Bipolar disorder . direct physiological effect substance abuse ; intoxication hallucinogen , inhalant , opioids , phencyclidine related substance . direct physiological effect psychostimulant antidepressant medication . Evidence clinically severe active disease , clinical finding unstable , opinion investigator , would negatively affect study medication would affect study medication . History seizure disorder , except febrile convulsion . Hospitalization period 3 week longer immediately prior randomization index manic episode . Known history intolerance hypersensitivity quetiapine lithium , component tablets/capsules . Known lack response quetiapine lithium , judge investigator . Use antipsychotic medication mood stabilizer quetiapine lithium day randomisation ( tapered discontinuation enrolment visit randomisation ) . Administration depot antipsychotic injection within 1 dose interval ( depot ) randomisation . Use clozapine within 28 day prior randomisation . Use antidepressants enrolment period within period 5 halflives drug ( ) prior randomisation . Continuous daily use benzodiazepine excess 4 mg per day lorazepam , equivalent , 28 day prior randomisation . Use drug induce inhibit hepatic metabolizing cytochrome 3A4 enzyme within 14 day randomisation . Receipt electroconvulsive therapy ( ECT ) within 28 day prior randomisation . Clinically significant deviation reference range clinical laboratory test result enrolment , judge investigator . An absolute neutrophil count ( ANC ) &lt; 1.5X109/L . Treatment quetiapine dosage least 50 mg/day enrolment ( Visit 1 ) Liver function test AST ALT 2 time upper normal limit . A thyroidstimulating hormone ( TSH ) concentration 10 % upper limit normal range laboratory use sample analysis enrolment , whether subject treat hypothyroidism . Known diagnosis Diabetes Mellitus ( DM ) fast blood glucose level &gt; upper normal limit . Risk transmit human immunodeficiency virus ( HIV ) hepatitis B via blood body fluid , judge investigator . ECG result consider clinically significant determine investigator . Conditions could affect absorption metabolism study medication . Patients investigators opinion require systematic psychotherapy ( supportive psychotherapy ) study period . Participation another clinical study compassionate use programme within 28 day prior randomisation , longer locally require . Involvement plan conduct study ( applies AstraZeneca staff investigational site ) . Previous enrolment randomisation treatment present study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Acute Mania</keyword>
	<keyword>Bipolar Disorder</keyword>
	<keyword>Quetiapine Fumarate</keyword>
	<keyword>Lithium</keyword>
</DOC>